医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

Trial of ENHERTU

DESTINY-Lung04 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Mutant Metastatic Non-Small Cell Lung Cancer

その他ヘルスバイオテクノロジーヘルスケアヘルス一般腫瘍学製薬　 TimeLine: DESTINY-Lung04 Phase Initiated in Patients with Previously Untreated HER2 Mutant Metastatic Non-Small Cell Lung Cancer Trial of ENHERTU

2021年12月23日

DESTINY-Breast11 Neoadjuvant Phase 3 Trial of ENHERTU® Initiated in Patients with High-Risk HER2 Positive Early-Stage Breast Cancer

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: DESTINY-Breast11 Neoadjuvant Phase Initiated in Patients with High-Risk HER2 Positive Early-Stage Breast Cancer Trial of ENHERTU

2021年11月30日

DESTINY-Gastric06 Phase 2 Trial of ENHERTU® Initiated in China in Patients with HER2 Positive Advanced Gastric Cancer

その他ヘルスバイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: DESTINY-Gastric06 Phase Initiated in China in Patients with HER2 Positive Advanced Gastric Cancer Trial of ENHERTU

2021年09月16日

DESTINY-CRC02 Phase 2 Trial of ENHERTU® Initiated in Patients with HER2 Overexpressing Advanced Colorectal Cancer

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: DESTINY-CRC02 Phase Initiated in Patients with HER2 Overexpressing Advanced Colorectal Cancer Trial of ENHERTU

2021年04月06日

DESTINY-Lung02 Phase 2 Trial of ENHERTU® Initiated in Patients with HER2 Mutated Metastatic Non-Small Cell Lung Cancer

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: DESTINY-Lung02 Phase Initiated in Patients with HER2 Mutated Metastatic Non-Small Cell Lung Cancer Trial of ENHERTU

2021年03月29日

DESTINY-Breast05 Head-to-Head Phase 3 Trial of ENHERTU® Versus T-DM1 Initiated in Patients with HER2 Positive Early Breast Cancer at High Risk After Neo-adjuvant Therapy

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: DESTINY-Breast05 Head-to-Head Phase Trial of ENHERTU Versus T-DM1 Initiated in Patients with HER2 Positive Early Breast Cancer at High Risk After Neo-adjuvant Therapy

2020年11月02日